Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer
May 1993
in “
Drugs & Therapy Perspectives
”
Studysummary Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer